ScreenerHero

XINTXintela AB (publ)

STO · SE · Healthcare · Biotechnology · xintela.se
0.1860SEK+0.54%Mkt Cap: 15.32M $P/E: —

Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM, which is in Phase I/IIa clinical developmen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap15.32M $
Enterprise Value16.47M $
Revenue (TTM)247.26K $
Gross Profit218.28K $
Net Income (TTM)-4.65M $
Revenue/Share0.0003 USD
Last Price0.1860 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.65
EV/Revenue66.61
P/S61.97
P/B-9.30
EPS (TTM)-0.07
EPS (Forward)—
52W Range
0.16107% of range0.5340
52W High0.5340 SEK
52W Low0.1610 SEK
Profitability
Gross Margin100.00%
Oper. Margin-2529.34%
EBITDA Margin0.00%
Profit Margin-2128.13%
ROE920.99%
ROA-167.32%
Growth
Revenue Growth216.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.98M $
CapEx (TTM)—
FCF Margin-1912.50%
FCF Yield-30.86%
Net Debt1.15M $
Net Debt/EBITDA-0.25
Balance Sheet
Debt/Equity-3.79
Current Ratio0.45
Quick Ratio0.41
Book Value/Sh-0.0200 SEK
Cash/Share0.0110 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.861.27M
Float399.50M
Insiders8.30%
Institutions65.54%
Technical
SMA 500.1941 (-4.2%)
SMA 2000.2452 (-24.2%)
Beta1.98
S&P 52W Chg19.18%
Avg Vol (30d)223.79K
Avg Vol (10d)262.89K
Technical Indicators
RSI (14)46.6
MACD-0.0029
MACD Signal-0.0037
MACD Hist.+0.0008
BB Upper0.1984 SEK
BB Middle0.1883 SEK
BB Lower0.1782 SEK
BB Width10.72%
ATR (14)0.0139 SEK
Vol Ratio (20d)0.66x